---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-24-000094"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:44:57.423189+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q3 revenue up 7.8% to $339.8M, non-GAAP EPS $0.86, raises guidance

## Summary
- Revenue $339.8M (+7.8% YoY); GAAP EPS $0.48 (+8.0%); non-GAAP EPS $0.86 (+21.1%).
- Non-GAAP operating margin 19.2% vs 17.4% prior year; free cash flow $120M in 9 months (+116%).
- Acquired assets from EndoGastric Solutions (EsophyX Z+ for GERD treatment).
- Entered asset purchase for Cook Medical lead management portfolio; closing expected Nov 1, 2024.
- Raised full-year guidance; specifics not detailed in press release excerpt.

## SEC filing metadata
- accession: 0000856982-24-000094
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/0000856982-24-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/mmsi-20241030x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-24-000094
- JSON: https://secwatch.observer/filing/0000856982-24-000094.json
- Plain text: https://secwatch.observer/filing/0000856982-24-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.